Advancements in p53-Based Anti-Tumor Gene Therapy Research

Yuanwan Peng1, Jinping Bai1, Wang Li1

  • 1Institute of Modern Fermentation Engineering and Future Foods, School of Light Industry and Food Engineering, Guangxi University, No. 100, Daxuedong Road, Nanning 530004, China.

PubMed

Insights

p53 gene therapy shows promise for cancer treatment but faces challenges. This review explores advances in p53 gene therapy and nucleic acid delivery to overcome these hurdles and support future development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The p53 gene is a critical tumor suppressor frequently altered in human cancers.
  • p53-based gene therapy is a promising strategy for cancer treatment.
  • Current p53 gene therapies face significant challenges including immaturity, safety concerns, limited efficacy, and patient acceptance.

Purpose of the Study:

  • To review recent advances in p53-based gene therapy.
  • To examine progress in nucleic acid delivery technologies for p53 gene therapy.
  • To provide insights and prospects for future development in this field.

Main Methods:

  • Literature review of p53 gene therapy.
  • Analysis of nucleic acid delivery systems.
  • Discussion of challenges and future directions.

Main Results:

  • Significant progress has been made in p53 gene therapy development.
  • Novel nucleic acid delivery technologies are emerging to improve therapeutic outcomes.
  • Despite challenges, the theoretical potential of p53 gene therapy remains high.

Conclusions:

  • Further research and technological advancements are crucial for overcoming current limitations.
  • Improved nucleic acid delivery systems are key to enhancing p53 gene therapy efficacy and safety.
  • p53 gene therapy holds considerable potential for future cancer treatment strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K